Content about antibodies

January 28, 2014

Pharmacists and nurse practitioners are trusted healthcare professionals who provide instructions and advice based on peer-reviewed guidelines and clinical data.

November 18, 2013

The global market for biosimilars is expected to be worth nearly $2 billion before the end of the decade, according to a new study.

October 10, 2013

When it comes to laws and regulations, what happens in Europe stays in Europe generally, and doesn’t have much bearing on the United States. But a recent win in Europe for U.S. drug maker Hospira could have some implications for the United States as well.

May 7, 2013

The global market for biosimilars will be worth nearly $2.5 billion this year, according to a new study.

January 17, 2013

The Food and Drug Administration on Wednesday approved Protein Sciences' Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology.

July 3, 2012

The Food and Drug Administration has approved over-the-counter sales of a test for the virus that causes AIDS, the agency said Tuesday.

June 6, 2012

A generic drug maker in India and a German pharmaceutical company will collaborate to develop biosimilars.

May 8, 2012

University of British Columbia researchers may have found a way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations, university officials announced Tuesday.

April 16, 2012

Children under the age of 10 years old may be especially susceptible to a new strain of influenza, according to an article published Friday in the Center for Disease Control and Prevention's "Morbidity and Mortality Weekly Report."

December 20, 2011

Generic drug maker Watson and biotech manufacturer Amgen will work together to develop biosimilar antibodies for treating cancer, the two companies said.

November 7, 2011

The first study to report the effects vitamin D has on the immune system of people with lupus was unveiled Saturday at the American College of Rheumatology Annual Scientific Meeting in Chicago.

October 11, 2011

Drug makers have 901 biotech drugs under development for more than 100 diseases ranging from cancers and infectious diseases to autoimmune disorders and cardiovascular diseases, the Pharmaceutical Research and Manufacturers of America said.


April 22, 2011

Many children with Type 1 diabetes have other autoimmune disorders as well, according to published reports.

January 7, 2011

Pfizer has paid Seattle Genetics $8 million to license its antibody technology, Seattle Genetics said Thursday.

December 21, 2010

In a deal that will bolster its drug development capabilities, Biogen Idec has acquired a subsidiary of Swiss-based Neurimmune Holding AG.

September 7, 2010

Swiss drug maker Lonza will help British drug maker GlaxoSmithKline manufacture five biotech drugs in...

June 21, 2010

The Food and Drug Administration has approved a new test for detecting HIV antigen and...

August 23, 2009

On the surface, this news highlights how serious the Centers for Disease Control and Prevention...

© 2014 Drug Store News. All Rights Reserved.